New pill shows promise for severe eczema relief

NCT ID NCT06996912

Summary

This study is testing whether an experimental oral medication called HSK44459 can improve skin symptoms and reduce itching in adults with moderate-to-severe atopic dermatitis (eczema). Researchers will compare two different doses of the medication against a placebo pill over 12 weeks in 150 participants. The goal is to see if this new treatment can significantly reduce eczema severity and itching for people who haven't responded well to standard treatments.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS (AD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Affiliated Dermatology Hospital of Shandong First Medical University

    Jinan, Shandong, 250022, China

Conditions

Explore the condition pages connected to this study.